Evidence map›Paper›PMID 23706700›Full record

Trial reportOphthalmology2013

Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema.

John H Kempen, Elizabeth A Sugar, Glenn J Jaffe, Nisha R Acharya, James P Dunn, Susan G Elner, Susan L Lightman, Jennifer E Thorne, Albert T Vitale, Michael M Altaweel and 1 more

Abstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Ophthalmology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Sub-Tenon's triamcinolone bridging to adalimumab therapy in refractory noninfectious uveitic macular edema.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  4. Article
  5. Serum Biomarkers of Vascular Involvement in Childhood Uveitis.Translational vision science & technology · 2024
    Article
  6. Article
  7. Are optical coherence tomography and fluorescein angiography comparable for detection of macular edema in Behçet uveitis?Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Article
  8. Involvement of the systemic microcirculation in pediatric uveitis.Pediatric rheumatology online journal · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Optical coherence tomography angiography (OCTA) as a new diagnostic tool in uveitis.Journal of ophthalmic inflammation and infection · 2019
    Review
  15. Article
  16. Update in treatment of uveitic macular edema.Drug design, development and therapy · 2019
    Review
  17. An investigation on optic nerve head involvement in Fuchs uveitis syndrome using optical coherence tomography and fluorescein angiography.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2018
    Article
  18. Article
  19. Morphological assessment of the retina in uveitis.Journal of ophthalmic inflammation and infection · 2016
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 2 countries.

John H KempenOcular Inflammation Service, Scheie Eye Institute, Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. john.kempen@uphs.upenn.edu
Elizabeth A Sugar
Glenn J Jaffe
Nisha R Acharya
James P Dunn
Susan G Elner
Susan L Lightman
Jennifer E Thorne
Albert T Vitale
Michael M Altaweel
Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group
Johns Hopkins University · USDuke University · USSan Francisco Foundation · USUniversity College London · GBUniversity of Michigan–Ann Arbor · USUniversity of Pennsylvania · USUniversity of Utah · USUniversity of Wisconsin–Madison · US

Funding

Multi-Center Uveitis Steriod Treatment (MUST) TrialU10EY014660 · NEI · JOHNS HOPKINS UNIVERSITY · PI HOLBROOK, JANET T. · 2004 to 2016
$33.6M
Multicenter Uveitis Steroid Treatment (MUST) TrialU10EY014655 · NEI · JOHNS HOPKINS UNIVERSITY · PI JABS, DOUGLAS A · 2004 to 2016
$4.6M
Reading Center: Multicenter Uveitis Steroid TrialU10EY014656 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI ALTAWEEL, MICHAEL M · 2004 to 2015
$2.2M
NEI NIH HHS U10 EY 014655NEI NIH HHS U10 EY014655NEI NIH HHS U10 EY 014656NEI NIH HHS U10 EY014656NEI NIH HHS U10 EY 014660NEI NIH HHS U10 EY014660
6 · The paper itself

Abstract

objectiveTo evaluate agreement between fluorescein angiography (FA) and optical coherence tomography (OCT) results for diagnosis of macular edema in patients with uveitis.

designMulticenter cross-sectional study.

participantsFour hundred seventy-nine eyes with uveitis from 255 patients.

methodsThe macular status of dilated eyes with intermediate uveitis, posterior uveitis, or panuveitis was assessed via Stratus-3 OCT and FA. To evaluate agreement between the diagnostic approaches, κ statistics were used.

main outcome measuresMacular thickening (MT; center point thickness, ≥ 240 μm per reading center grading of OCT images) and macular leakage (ML; central subfield fluorescein leakage, ≥ 0.44 disc areas per reading center grading of FA images), and agreement between these outcomes in diagnosing macular edema.

resultsOptical coherence tomography (90.4%) more frequently returned usable information regarding macular edema than FA (77%) or biomicroscopy (76%). Agreement in diagnosis of MT and ML (κ = 0.44) was moderate. Macular leakage was present in 40% of cases free of MT, whereas MT was present in 34% of cases without ML. Biomicroscopic evaluation for macular edema failed to detect 40% and 45% of cases of MT and ML, respectively, and diagnosed 17% and 17% of cases with macular edema that did not have MT or ML, respectively; these results may underestimate biomicroscopic errors (ophthalmologists were not explicitly masked to OCT and FA results). Among eyes free of ML, phakic eyes without cataract rarely (4%) had MT. No factors were found that effectively ruled out ML when MT was absent.

conclusionsOptical coherence tomography and FA offered only moderate agreement regarding macular edema status in uveitis cases, probably because what they measure (MT and ML) are related but nonidentical macular pathologic characteristics. Given its lower cost, greater safety, and greater likelihood of obtaining usable information, OCT may be the best initial test for evaluation of suspected macular edema. However, given that ML cannot be ruled out if MT is absent and vice versa, obtaining the second test after negative results on the first seems justified when detection of ML or MT would alter management. Given that biomicroscopic evaluation for macular edema erred frequently, ancillary testing for macular edema seems indicated when knowledge of ML or MT status would affect management. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

Indexed as

Fluorescein AngiographyTomography, Optical CoherenceCapillary PermeabilityCross-Sectional StudiesDrug ImplantsFemaleFluocinolone AcetonideGlucocorticoidsHumansMacular EdemaMaleMiddle AgedPanuveitisRetinaRetinal VesselsSensitivity and SpecificityDrug ImplantsFluocinolone AcetonideGlucocorticoids

Identifiers

PMID23706700
PMCPMC3758459
OpenAlexW2022963359

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.